TrialPLoS neglected tropical diseases2016

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.

Jason W Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.